Related Experiment Video

Updated: Oct 15, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

[Results of treatment of lupus nephritis in children. Own experience]

J Kwinta-Rybicka1, K Sancewicz-Pach

  • 1Kliniki Nefrologii Dzieciecej Katedry Pediatrii Polsko-Amerykańskiego Instytutu Pediatrii Wydziału Lekarskiego UJ w Krakowie.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|July 18, 2000
PubMed

Insights

A more aggressive treatment approach for pediatric lupus nephritis, involving intravenous cyclophosphamide pulses and methylprednisolone, resulted in higher remission rates (81%) compared to standard corticosteroid therapy (53%). This study highlights improved outcomes with intensified treatment protocols.

Area of Science:

  • Pediatric Nephrology
  • Immunology
  • Rheumatology

Context:

  • Lupus nephritis is a severe complication of Systemic Lupus Erythematosus (SLE) in children.
  • Treatment protocols for pediatric lupus nephritis have evolved over time.
  • Assessing treatment efficacy is crucial for improving patient outcomes.

Purpose:

  • To compare the efficacy of two different treatment regimens for pediatric lupus nephritis.
  • To evaluate the impact of an intensified treatment protocol on remission rates in children with lupus nephritis.

Summary:

  • This study assessed lupus nephritis treatment in 31 children (aged 4-16).
  • Group 1 (1980-92) received corticosteroids and alkylating agents (53% remission).
  • Group 2 (1993-98) received intensified therapy: monthly intravenous cyclophosphamide pulses and methylprednisolone, achieving 81% remission.

Impact:

  • The findings suggest that a more aggressive, intensified treatment regimen significantly improves remission rates in pediatric lupus nephritis.
  • This research provides evidence for optimizing treatment strategies in pediatric rheumatology and nephrology.
  • The study underscores the importance of tailored and aggressive therapeutic approaches for severe autoimmune conditions in children.

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...